Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder ; volume:13 ; number:1 ; day:8 ; month:8 ; year:2023 ; pages:1-11 ; date:12.2023
Translational Psychiatry ; 13, Heft 1 (8.8.2023), 1-11, 12.2023
- Creator
-
Santoro, Jonathan D.
Spinazzi, Noemi A.
Filipink, Robyn A.
Hayati-Rezvan, Panteha
Kammeyer, Ryan
Patel, Lina
Sannar, Elise A.
Dwyer, Luke
Banerjee, Abhik K.
Khoshnood, Mellad
Jafarpour, Saba
Boyd, Natalie K.
Partridge, Rebecca
Gombolay, Grace Y.
Christy, Alison L.
Real de Asua, Diego
Carmen Ortega, Maria del
Manning, Melanie A.
Mater, Heather Van
Worley, Gordan
Franklin, Cathy
Stanley, Maria A.
Brown, Ruth
Capone, George T.
Quinn, Eileen A.
Rafii, Michael S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-023-02579-z
- URN
-
urn:nbn:de:101:1-2024020612574546348953
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Santoro, Jonathan D.
- Spinazzi, Noemi A.
- Filipink, Robyn A.
- Hayati-Rezvan, Panteha
- Kammeyer, Ryan
- Patel, Lina
- Sannar, Elise A.
- Dwyer, Luke
- Banerjee, Abhik K.
- Khoshnood, Mellad
- Jafarpour, Saba
- Boyd, Natalie K.
- Partridge, Rebecca
- Gombolay, Grace Y.
- Christy, Alison L.
- Real de Asua, Diego
- Carmen Ortega, Maria del
- Manning, Melanie A.
- Mater, Heather Van
- Worley, Gordan
- Franklin, Cathy
- Stanley, Maria A.
- Brown, Ruth
- Capone, George T.
- Quinn, Eileen A.
- Rafii, Michael S.
- SpringerLink (Online service)
Other Objects (12)
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder
Altered endotoxin responsiveness in healthy children with Down syndrome
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Synthetic immunity to break down the bottleneck of cancer immunotherapy
The Relapse
Down Down Down
Down Down Down
Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression
De novo variants in immune regulatory genes in Down syndrome regression disorder
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder
Altered endotoxin responsiveness in healthy children with Down syndrome
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Synthetic immunity to break down the bottleneck of cancer immunotherapy
The Relapse
Down Down Down
Down Down Down
Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression
De novo variants in immune regulatory genes in Down syndrome regression disorder
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder
Altered endotoxin responsiveness in healthy children with Down syndrome
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Synthetic immunity to break down the bottleneck of cancer immunotherapy
The Relapse
Down Down Down
Down Down Down
Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression
De novo variants in immune regulatory genes in Down syndrome regression disorder